KOHN; Kenneth I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOHN; Kenneth I..The latest application filed is for "smart nutrition dosing".

Company Profile

2.4.17

KOHN; Kenneth I. - West Bloomfield MI
- unknown

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Smart Nutrition Dosing App 20220028527 - INWALD; David ; et al.	2022-01-27
Smart Dosing For Cancer Therapy App 20220028512 - KOHN; Kenneth I.	2022-01-27
Application For Tracking Infectious Disease App 20210375485 - KOHN; Kenneth I. ; et al.	2021-12-02
Smart Multidosing App 20210319870 - INWALD; David ; et al.	2021-10-14
Smart Dosing For Cancer Therapy App 20210193332 - INWALD; David ; et al.	2021-06-24
Smart Multidosing App 20200245925 - Kind Code	2020-08-06
Vent balloon Grant 10588996 -	2020-03-17
Gene Editing Methods And Compositions For Eliminating Risk Of Jc Virus Activation And Pml (progressive Multifocal Leukoencephalo App 20190247470 - Khalili; Kamel ; et al.	2019-08-15
Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy Grant 10,279,014 - Khalili , et al.	2019-05-07
Gene Editing Methods And Compositions For Eliminating Risk Of Jc Virus Activation And Pml (progressive Multifocal Leukoencephalopathy) During Immunosuppressive Therapy App 20180140682 - Khalili; Kamel ; et al.	2018-05-24
Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation Grant 9,925,204 - Kawai , et al. March 27, 2	2018-03-27
Methods And Compositions For Reversing Disruption Of The Glycocalyx, Inflammation, And Oxidative Damage App 20180036285 - Tunac; Josefino B. ; et al.	2018-02-08
Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage Grant 9,867,842 - Tunac , et al. January 16, 2	2018-01-16
Methods And Compositions For Reversing Disruption Of The Glycocalyx, Inflammation, And Oxidative Damage App 20170080006 - Tunac; Josefino B. ; et al.	2017-03-23
Method Of Extending Half-life Of Crystaline Antibodies App 20170056504 - Kohn; Kenneth I. ; et al.	2017-03-02
Anti-inflammatory Compounds In Combination With Hydrogen For The Treatment Of Inflammation App 20160317575 - Kawai; Toshihisa ; et al.	2016-11-03
Cholesterol-lowering Compounds In Combination With Lipid Metabolism-altering Compounds Of Non-absorbable Sugars, Compounds That Convert Nh3 To Nh4+, Or Hydrogen-generating Compounds For The Treatment Of High Cholesterol And Inflammation App 20150335615 - Kawai; Toshihisa ; et al.	2015-11-26
Anti-inflammatory Compounds In Combination With Hydrogen For The Treatment Of Inflammation App 20150140090 - Kawai; Toshihisa ; et al.	2015-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.